CN103068807B - 通过使用钯化合物的偶合法的苯基取代杂环衍生物的制备方法 - Google Patents
通过使用钯化合物的偶合法的苯基取代杂环衍生物的制备方法 Download PDFInfo
- Publication number
- CN103068807B CN103068807B CN201180041695.2A CN201180041695A CN103068807B CN 103068807 B CN103068807 B CN 103068807B CN 201180041695 A CN201180041695 A CN 201180041695A CN 103068807 B CN103068807 B CN 103068807B
- Authority
- CN
- China
- Prior art keywords
- acid
- silver
- copper
- palladium
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KIUHCRRYPAIVEE-BFHBGLAWSA-N CC(C)COC(C=CC([C@@H]1C)Br)=C1C#N Chemical compound CC(C)COC(C=CC([C@@H]1C)Br)=C1C#N KIUHCRRYPAIVEE-BFHBGLAWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/26—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
Claims (22)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010-190760 | 2010-08-27 | ||
JP2010190760 | 2010-08-27 | ||
PCT/JP2011/069250 WO2012026565A1 (ja) | 2010-08-27 | 2011-08-26 | パラジウム化合物を用いたカップリング法によるフェニル置換複素環誘導体の製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103068807A CN103068807A (zh) | 2013-04-24 |
CN103068807B true CN103068807B (zh) | 2016-05-25 |
Family
ID=45723554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180041695.2A Active CN103068807B (zh) | 2010-08-27 | 2011-08-26 | 通过使用钯化合物的偶合法的苯基取代杂环衍生物的制备方法 |
Country Status (20)
Country | Link |
---|---|
US (1) | US8916714B2 (zh) |
EP (1) | EP2610248B1 (zh) |
JP (1) | JP5654601B2 (zh) |
KR (1) | KR101800054B1 (zh) |
CN (1) | CN103068807B (zh) |
AU (1) | AU2011294204B2 (zh) |
BR (1) | BR112013003992B1 (zh) |
CA (1) | CA2807543C (zh) |
DK (1) | DK2610248T3 (zh) |
ES (1) | ES2589977T3 (zh) |
HK (1) | HK1179960A1 (zh) |
HU (1) | HUE030166T2 (zh) |
IL (1) | IL224923A (zh) |
MX (1) | MX353203B (zh) |
PL (1) | PL2610248T3 (zh) |
PT (1) | PT2610248T (zh) |
RU (1) | RU2563459C2 (zh) |
SG (1) | SG187843A1 (zh) |
TW (1) | TWI554505B (zh) |
WO (1) | WO2012026565A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010218748B2 (en) * | 2009-02-27 | 2015-03-26 | Teijin Limited | Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst |
US20170144987A1 (en) * | 2014-05-13 | 2017-05-25 | Teijin Pharma Limited | Novel crystalline polymorphs of pyridine derivative and method for producing the same |
CN110156698B (zh) * | 2019-06-06 | 2020-10-13 | 沈阳海诺威医药科技有限公司 | 2-苯基-1,6-二氢嘧啶-5-甲酸衍生物的制备方法和用途 |
CN110683926B (zh) * | 2019-09-29 | 2022-11-04 | 北京大学深圳研究生院 | 羧酸芳基酯类化合物的制备方法 |
CN110698431B (zh) * | 2019-11-20 | 2022-07-01 | 陕西师范大学 | 一种1,2-苯并噻嗪类化合物的合成方法 |
CN113731406B (zh) * | 2021-10-12 | 2023-07-28 | 南京工业大学 | 一种提高钯碳活性加氢脱除保护基的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004069394A2 (en) * | 2003-02-03 | 2004-08-19 | The Trustees Of Columbia University In The City Of New York | Synthetic method for direct arylation of heterocyclic arenes |
CN1914197A (zh) * | 2004-02-02 | 2007-02-14 | 诺瓦提斯公司 | 可用于制备(1h-四唑-5-基)-联苯衍生物的偶联反应 |
WO2010098428A1 (ja) * | 2009-02-27 | 2010-09-02 | 帝人ファーマ株式会社 | 遷移金属触媒を用いたカップリング法によるフェニル置換複素環誘導体の製造法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346094A (en) | 1980-09-22 | 1982-08-24 | Eli Lilly And Company | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
US4495195A (en) | 1982-11-01 | 1985-01-22 | Eli Lilly And Company | Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use |
DK0513379T3 (da) | 1990-11-30 | 1996-09-30 | Teijin Ltd | 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne |
JP3399559B2 (ja) | 1992-08-12 | 2003-04-21 | 帝人株式会社 | 2−フェニル複素環式化合物 |
JP3113110B2 (ja) | 1993-01-19 | 2000-11-27 | 帝人株式会社 | イソキサゾールおよびイソチアゾール誘導体 |
JP3169735B2 (ja) | 1993-04-08 | 2001-05-28 | 帝人株式会社 | (アルコキシシアノフェニル)チアゾール誘導体の製造方法 |
JP2706037B2 (ja) | 1993-04-13 | 1998-01-28 | 帝人株式会社 | シアノ化合物およびその製造方法 |
JP2834971B2 (ja) | 1993-05-25 | 1998-12-14 | 帝人株式会社 | 2−(4−アルコキシ−3−シアノフェニル)チアゾール誘導体の製造法およびその新規製造中間体 |
ID21775A (id) | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
JPH10139770A (ja) | 1996-11-08 | 1998-05-26 | Teijin Ltd | 2−(3−シアノフェニル)チアゾール誘導体の製造法 |
JPH10310578A (ja) | 1996-11-13 | 1998-11-24 | Yoshitomi Pharmaceut Ind Ltd | 3−フェニルピラゾール化合物 |
JP3440196B2 (ja) | 1997-08-13 | 2003-08-25 | 帝人株式会社 | チオベンズアミド誘導体の製造方法 |
CN1406127A (zh) | 2000-02-23 | 2003-03-26 | 奥尔顿有限公司 | 噻唑鎓类化合物和与蛋白老化有关的疾病的治疗 |
WO2002051849A1 (fr) | 2000-12-26 | 2002-07-04 | Daiichi Pharmaceutical Co., Ltd. | Inhibiteurs cdk4 |
NZ542153A (en) * | 2003-02-10 | 2009-01-31 | Vertex Pharma | Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes |
RU2006111093A (ru) | 2003-09-06 | 2007-10-27 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы атр-связывающих кассетных транспортеров |
ES2791303T3 (es) | 2004-01-30 | 2020-11-03 | Vertex Pharma | Compuesto intermedio de moduladores de transportadores de casete de unión a ATP |
ES2383766T3 (es) * | 2006-02-24 | 2012-06-26 | Astellas Pharma Inc. | Remedio o preventivo para úlcera digestiva |
-
2011
- 2011-08-26 WO PCT/JP2011/069250 patent/WO2012026565A1/ja active Application Filing
- 2011-08-26 HU HUE11820025A patent/HUE030166T2/en unknown
- 2011-08-26 CN CN201180041695.2A patent/CN103068807B/zh active Active
- 2011-08-26 RU RU2013113576/04A patent/RU2563459C2/ru active
- 2011-08-26 ES ES11820025.2T patent/ES2589977T3/es active Active
- 2011-08-26 US US13/818,538 patent/US8916714B2/en active Active
- 2011-08-26 AU AU2011294204A patent/AU2011294204B2/en active Active
- 2011-08-26 MX MX2013001768A patent/MX353203B/es active IP Right Grant
- 2011-08-26 DK DK11820025.2T patent/DK2610248T3/en active
- 2011-08-26 PT PT118200252T patent/PT2610248T/pt unknown
- 2011-08-26 JP JP2012530728A patent/JP5654601B2/ja active Active
- 2011-08-26 BR BR112013003992-2A patent/BR112013003992B1/pt active IP Right Grant
- 2011-08-26 EP EP11820025.2A patent/EP2610248B1/en active Active
- 2011-08-26 CA CA2807543A patent/CA2807543C/en active Active
- 2011-08-26 TW TW100130694A patent/TWI554505B/zh active
- 2011-08-26 KR KR1020137007451A patent/KR101800054B1/ko active IP Right Grant
- 2011-08-26 PL PL11820025.2T patent/PL2610248T3/pl unknown
- 2011-08-26 SG SG2013010954A patent/SG187843A1/en unknown
-
2013
- 2013-02-26 IL IL224923A patent/IL224923A/en active IP Right Grant
- 2013-06-19 HK HK13107170.2A patent/HK1179960A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004069394A2 (en) * | 2003-02-03 | 2004-08-19 | The Trustees Of Columbia University In The City Of New York | Synthetic method for direct arylation of heterocyclic arenes |
CN1914197A (zh) * | 2004-02-02 | 2007-02-14 | 诺瓦提斯公司 | 可用于制备(1h-四唑-5-基)-联苯衍生物的偶联反应 |
WO2010098428A1 (ja) * | 2009-02-27 | 2010-09-02 | 帝人ファーマ株式会社 | 遷移金属触媒を用いたカップリング法によるフェニル置換複素環誘導体の製造法 |
Non-Patent Citations (7)
Title |
---|
Catalytic Direct Arylation with Aryl Chlorides,Bromides,and lodides:Intramolecular studies leading to new intermolecular reactions;Louis-Charles Campeau,等;《J.AM.CHEM.SOC.》;20051216;第128卷(第2期);第586页右栏 * |
Direct C-2 Arylation of Alkyl 4-Thiazolecarboxylates: New Insights in Synthesis of Heterocyclic Core of Thiopeptide Antibiotics;Thibaut Martin,等;《Organic Letters》;20080610;第10卷(第13期);第2911页 * |
Efficient and highly regioselective direct C-2 arylation of azoles, including free (NH)-imidazole, -benzimidazole and –indole, with aryl halides;Fabio Bellina,等;《Tetrahedron》;20061227;第63卷(第9期);第1972页 * |
Nickel-Catalyzed Biaryl Coupling of Heteroarenes and Aryl Halides/Triflates;Jerome Canivet,等;《Organic Letters》;20090318;第11卷(第8期);第1736页Scheme 3 * |
Palladium(0) nanoparticles-catalyzed ligand-free direct arylation of benzothiazole via C-H bond functionalization;Debasree Saha,等;《Tetrahedron Letters》;20100824;第51卷(第42期);第5626页 * |
Palladium-Catalyzed Benzene Arylation: Incorporation of Catalytic Pivalic Acid as a Proton Shuttle and a Key Element in Catalyst Design;Marc Lafrance,等;《J. AM. CHEM. SOC.》;20061209;第128卷(第51期);第16496页 * |
Transition-Metal-Catalyzed Direct Arylation of (Hetero)Arenes by C-H Bond Cleavage;Lutz Ackermann,等;《Angew.Chem.Int.Ed.》;20091221;第48卷(第52期);第9802-9811页 * |
Also Published As
Publication number | Publication date |
---|---|
US20130158272A1 (en) | 2013-06-20 |
ES2589977T3 (es) | 2016-11-17 |
MX353203B (es) | 2018-01-05 |
CN103068807A (zh) | 2013-04-24 |
CA2807543A1 (en) | 2012-03-01 |
TW201305122A (zh) | 2013-02-01 |
CA2807543C (en) | 2018-08-28 |
AU2011294204B2 (en) | 2015-07-23 |
KR101800054B1 (ko) | 2017-11-21 |
JPWO2012026565A1 (ja) | 2013-10-28 |
WO2012026565A1 (ja) | 2012-03-01 |
RU2563459C2 (ru) | 2015-09-20 |
IL224923A (en) | 2017-07-31 |
AU2011294204A1 (en) | 2013-03-21 |
PL2610248T3 (pl) | 2016-12-30 |
TWI554505B (zh) | 2016-10-21 |
RU2013113576A (ru) | 2014-10-10 |
US8916714B2 (en) | 2014-12-23 |
PT2610248T (pt) | 2016-08-23 |
KR20130138219A (ko) | 2013-12-18 |
EP2610248B1 (en) | 2016-06-08 |
SG187843A1 (en) | 2013-03-28 |
HK1179960A1 (zh) | 2013-10-11 |
DK2610248T3 (en) | 2016-07-25 |
MX2013001768A (es) | 2013-03-22 |
BR112013003992B1 (pt) | 2021-07-20 |
BR112013003992A2 (pt) | 2016-07-12 |
EP2610248A1 (en) | 2013-07-03 |
EP2610248A4 (en) | 2013-10-16 |
JP5654601B2 (ja) | 2015-01-14 |
HUE030166T2 (en) | 2017-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103068807B (zh) | 通过使用钯化合物的偶合法的苯基取代杂环衍生物的制备方法 | |
CN102333765B (zh) | 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法 | |
Chen et al. | Acetonitrile-dependent oxyphosphorylation: A mild one-pot synthesis of β-ketophosphonates from alkenyl acids or alkenes | |
Casas et al. | Pyridoxal thiosemicarbazonate monohydrate of dimethylthallium (III): X-ray structure and spectroscopic properties | |
Cucciolito et al. | Preparation, structure, and metal coordination of 2-(2-methyl-2, 3-dihydro-1H-perimidin-2-yl) benzene-1, 3-diol | |
CN106715396B (zh) | 光学活性α-三氟甲基-β-氨基酸衍生物的制备方法 | |
Xu et al. | A Facile and Practical Process for the Synthesis of Polysubstituted Furans from Alkynes Using Atmospheric Oxygen as a Terminal Oxidant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1179960 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Komiyama Masato Inventor before: Komiyama Masato |
|
COR | Change of bibliographic data | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1179960 Country of ref document: HK |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180129 Address after: Osaka City, Osaka of Japan Patentee after: teijin limited Address before: Tokyo, Japan, Japan Patentee before: Teijin Pharma Ltd. |